Dr Reddy’s Q3 results: Net profit grows 2% to ₹1,403.8 crore, revenue surges 16%
Dr. Reddy’s Laboratories Ltd, one of India’s leading pharmaceutical giants, reported its financial results for the third quarter of the fiscal year 2024-25 (Q3 FY25) on Thursday, January 23, 2025. The company’s net profit witnessed a modest 1.8% year-on-year (YoY) growth, reaching ₹1,403.8 crore in Q3 FY25, compared to ₹1,378.9 crore in the corresponding quarter…